FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1566853467> ?p ?o ?g. }

• W1566853467 endingPage "IN15" @default.
• W1566853467 startingPage "605" @default.
• W1566853467 abstract "Ovarian cancer patients treated with cisplatin-based chemotherapy often develop acquired cisplatin resistance and, consequently, cancer recurrence. We have previously reported that annexin A11 is associated with cisplatin resistance and related to tumor recurrence in ovarian cancer patients. In this study, we used small interfering RNA to suppress annexin A11 expression in ovarian cancer cells followed by various in vitro assays. We showed that knockdown of annexin A11 expression reduced cell proliferation and colony formation ability of ovarian cancer cells. Epigenetic silencing of annexin A11 conferred cisplatin resistance to ovarian cancer cells. Through a comprehensive time course study of cisplatin response in ovarian cancer cells with/without suppression of annexin A11 expression using whole-genome oligonucleotide microarrays, we identified a set of differentially expressed genes associated with annexin A11 expression and some patterns of gene expressions in response to cisplatin exposure. These identified genes/patterns were further validated by real-time polymerase chain reaction and immunoblot analysis. Many of them such as HMOX1, TGFBI, LY6D, S100P, EIF4EBP2, DHRS2, and PCSK9 have been involved in apoptosis, cell cycling/proliferation, cell adhesion/migration, transcription regulation, and signal transduction. In addition, immunohistochemistry analyses indicated that annexin A11 immunointensity inversely correlated with HMOX1 immunoreactivity in 142 ovarian cancer patients. In contrast to annexin A11, HMOX1 immunoreactivity positively correlated with in vitro cisplatin resistance in ovarian cancers. Collectively, annexin A11 is directly involved in cell proliferation and cisplatin resistance of ovarian cancer. Manipulation of annexin A11 and its associated genes may represent a novel therapeutic strategy in human ovarian cancers." @default.
• W1566853467 created "2016-06-24" @default.
• W1566853467 creator A5000487659 @default.
• W1566853467 creator A5014887786 @default.
• W1566853467 creator A5078939311 @default.
• W1566853467 creator A5079992055 @default.
• W1566853467 date "2009-06-01" @default.
• W1566853467 modified "2023-10-05" @default.
• W1566853467 title "Suppression of Annexin A11 in Ovarian Cancer: Implications in Chemoresistance" @default.
• W1566853467 cites W1506940213 @default.
• W1566853467 cites W1576215795 @default.
• W1566853467 cites W1965392984 @default.
• W1566853467 cites W1966536078 @default.
• W1566853467 cites W1974806304 @default.
• W1566853467 cites W1975042178 @default.
• W1566853467 cites W1977002958 @default.
• W1566853467 cites W1985045616 @default.
• W1566853467 cites W2000926853 @default.
• W1566853467 cites W2003594160 @default.
• W1566853467 cites W2004783362 @default.
• W1566853467 cites W2005806432 @default.
• W1566853467 cites W2014910631 @default.
• W1566853467 cites W2015757920 @default.
• W1566853467 cites W2020056775 @default.
• W1566853467 cites W2021599981 @default.
• W1566853467 cites W2028946225 @default.
• W1566853467 cites W2034701758 @default.
• W1566853467 cites W2038809726 @default.
• W1566853467 cites W2043103956 @default.
• W1566853467 cites W2056583667 @default.
• W1566853467 cites W2059885092 @default.
• W1566853467 cites W2060358031 @default.
• W1566853467 cites W2071765283 @default.
• W1566853467 cites W2080798710 @default.
• W1566853467 cites W2098142356 @default.
• W1566853467 cites W2103891110 @default.
• W1566853467 cites W2115413209 @default.
• W1566853467 cites W2115852285 @default.
• W1566853467 cites W2131947231 @default.
• W1566853467 cites W2136973375 @default.
• W1566853467 cites W2164277862 @default.
• W1566853467 cites W2166933821 @default.
• W1566853467 cites W4233920089 @default.
• W1566853467 doi "https://doi.org/10.1593/neo.09286" @default.
• W1566853467 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2685449" @default.
• W1566853467 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19484149" @default.
• W1566853467 hasPublicationYear "2009" @default.
• W1566853467 type Work @default.
• W1566853467 sameAs 1566853467 @default.
• W1566853467 citedByCount "46" @default.
• W1566853467 countsByYear W15668534672012 @default.
• W1566853467 countsByYear W15668534672014 @default.
• W1566853467 countsByYear W15668534672015 @default.
• W1566853467 countsByYear W15668534672016 @default.
• W1566853467 countsByYear W15668534672017 @default.
• W1566853467 countsByYear W15668534672018 @default.
• W1566853467 countsByYear W15668534672019 @default.
• W1566853467 countsByYear W15668534672020 @default.
• W1566853467 countsByYear W15668534672021 @default.
• W1566853467 countsByYear W15668534672022 @default.
• W1566853467 countsByYear W15668534672023 @default.
• W1566853467 crossrefType "journal-article" @default.
• W1566853467 hasAuthorship W1566853467A5000487659 @default.
• W1566853467 hasAuthorship W1566853467A5014887786 @default.
• W1566853467 hasAuthorship W1566853467A5078939311 @default.
• W1566853467 hasAuthorship W1566853467A5079992055 @default.
• W1566853467 hasBestOaLocation W15668534671 @default.
• W1566853467 hasConcept C104317684 @default.
• W1566853467 hasConcept C119056186 @default.
• W1566853467 hasConcept C121608353 @default.
• W1566853467 hasConcept C153911025 @default.
• W1566853467 hasConcept C190283241 @default.
• W1566853467 hasConcept C2776694085 @default.
• W1566853467 hasConcept C2778239845 @default.
• W1566853467 hasConcept C2780427987 @default.
• W1566853467 hasConcept C502942594 @default.
• W1566853467 hasConcept C54355233 @default.
• W1566853467 hasConcept C62112901 @default.
• W1566853467 hasConcept C86803240 @default.
• W1566853467 hasConcept C88634738 @default.
• W1566853467 hasConcept C96232424 @default.
• W1566853467 hasConceptScore W1566853467C104317684 @default.
• W1566853467 hasConceptScore W1566853467C119056186 @default.
• W1566853467 hasConceptScore W1566853467C121608353 @default.
• W1566853467 hasConceptScore W1566853467C153911025 @default.
• W1566853467 hasConceptScore W1566853467C190283241 @default.
• W1566853467 hasConceptScore W1566853467C2776694085 @default.
• W1566853467 hasConceptScore W1566853467C2778239845 @default.
• W1566853467 hasConceptScore W1566853467C2780427987 @default.
• W1566853467 hasConceptScore W1566853467C502942594 @default.
• W1566853467 hasConceptScore W1566853467C54355233 @default.
• W1566853467 hasConceptScore W1566853467C62112901 @default.
• W1566853467 hasConceptScore W1566853467C86803240 @default.
• W1566853467 hasConceptScore W1566853467C88634738 @default.
• W1566853467 hasConceptScore W1566853467C96232424 @default.
• W1566853467 hasIssue "6" @default.
• W1566853467 hasLocation W15668534671 @default.
• W1566853467 hasLocation W15668534672 @default.

• next